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Abstract.
This paper describes the construction of a labeless immunosensor for the
antibiotic ciprofloxacin and its interrogation using an AC impedance protocol.
Commercial screen-printed carbon electrodes were used as the basis for the sensor.
Polyaniline was electrodeposited onto the sensors and then utilised to immobilise a
biotinylated antibody for ciprofloxacin using classical avidin-biotin interactions.
Electrodes containing the antibodies were exposed to solutions of antigen and
interrogated using an AC impedance protocol. The faradaic component of the
impedance of the electrodes was found to increase with increasing concentration of
antigen. Control samples containing a non-specific IgG antibody were also studied and
calibration curves obtained by subtraction of the responses for specific and non-specific
antibody based sensors, thereby eliminating the effects of non-specific adsorption of
antigen.
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INTRODUCTION
The principle of immunoas says was established in 1959 by Yalow and Berson
(Yalow & Berson, 1959). Their work developed the widely used radioimmunoassay to
examine the properties of insulin-binding antibodies in human serum, using samples
obtained from subjects that had been treated with insulin.
Following the newly developed immunoassay technique, the concept of a
biosensor was pioneered by Clark and Lyons in 1962 (Clark & Lyons, 1962). The
original methodology was to immobilise enzymes on the surface of electrochemical
sensors-assuming that this would enhance the ability of a sensor to detect specific
analytes. This idea has remained virtually unchanged since this original design,
however, technological advances have allowed for the expansion of this field of science.
The incorporation of antibodies into conducting polymer films was first reported
in 1991 (John et al 1991). Anti-human serum albumin (anti-HSA) was incorporated into
a polypyrrole film, which was galvanostatically polymerised onto a platinum wire
substrate. When grown in the absence of a counterion, a poor polymeric film, both in
appearance and electrochemical properties was formed, suggesting that the presence of
a counterion was necessary for the polymerisation process to be successful. Amino acid
analysis of the polymer using a leucine marker showed that approximately 0.1% w/v
(0.2 Pg) of the antibody was incorporated into
the matrix. When the pyrrole anti-HSA electrode was exposed to 50 Pg ml-1 HSA for ten
minutes, a new reduction peak was observed at a potential of approximately +600mV
vs. Ag/AgCl. This peak increased in magnitude after a further thirty minutes in the same
solution and it was suggested this could be due to an antibody/antigen interaction with
the polymer. Further work by the same group gave rise to reports of a
reversible real-time immunosensor (John et al 1991). Other early work utilised a pulsed
amperometric detection technique for other analytes, including p-cresol (Barnett et al
1994), Thaumatin (Sadik et al 1994) and polychlorinated biphenyls (Bender and Sadik
1994). Since this work there has been a huge increase in the development of
electrochemical immunosensors as detailed in several recent reviews (Rodriguez-Mozaz
et al 2006, Diaz-Gonzalez et al 2005, Cosnier 2005).
Antibody-antigen interactions are by their very nature complex and the
reproducible response characteristics of immunosensors requires that the affinity
reaction occurring is minimally perturbed by the fabrication procedure. We have
previously shown that up to 2-3 Pg antibodies for BSA and digoxin may be successfully
incorporated into conducting polymer films by entrapment in a growing polypyrrole
film with no detrimental effect to antibody activity (Grant et al 2003). Electrochemical
interrogation of these films demonstrated selective interactions with the target antigens.
Further work utilised an AC impedance protocol (Grant et al 2005) as the method of
interrogation for these films and led to the development of immunosensors for digoxin
and bovine serum albumin.
The quinolones are a family of broad-spectrum antibiotics with the majority of
quinolones in clinical use being fluoroquinolones, which have a fluoro group attached to
the central ring system. They are widely used within adult patients because of excellent
tissue penetration which makes them extremely effective against bacteria that grow
intracellularly such as salmonella (Gendrei et al 2003). One of this group is
ciprofloxacin (Figure 1) which is a broad-spectrum antibiotic active against many
bacteria including anthrax (Torriero et al 2006). Many of these fluoroquinolones are
added to farm animal feed since they can lead to greater and more rapid weight gain.
Unfortunately the effect of this is thought to have enabled the rise of resistant species of
bacteria (Gendrei et al 2003).
The monitoring of fluoroquinolones within both food and the environment is
important since these antibiotics have potential health and environmental damaging
effects. Ciprofloxacin concentrations in hospital wastewaters were monitored and
correlations with DNA damaging effects made (Hartmann et al 1999). Levels of
ciprofloxacin in hospital outflow water between 0.7-124.5 ng ml-1 were measured using
HPLC (Hartmann et al 1999) and shown to display genotoxicity at levels as low as 5.2
ng ml-1. Similar work (Batt et al 2006) measured wastewater ciprofloxacin using
LC/MS/MS and found levels between 0.031-5.6 ng ml-1 (even after treatment) with a
limit of detection of 0.030 ng ml-1. Levels in vivo have also been widely studied with
the therapeutic ranges typically being between 0.57-2.30 Pg ml-1 in serum and 1.26-4.03
Pg g-1 in tissue (Licitra et al 1987).
A recent publication (Torriero et al 2006) details the use of a horseradish
peroxidase based biosensor for the detection of ciprofloxacin due to its inhibition of the
oxidation of catechol, however other piperazine based compounds could potentially
interfere with this determination. Linear responses were obtained between 0.02-65 PM
with the limit of detection being 0.4 nM. We have within this work developed a labeless
immunosensor for ciprofloxacin as a typical fluoroquinolone. The sensor utilises screen-
printed carbon electrodes, modified by deposition of first, a conducting polymer
(polyaniline) which is then modified with biotinylating reagent. Complexion of the
immobilised biotin with avidin allows the further binding of biotinylated antibodies via
standard avidin-biotin interactions (Figure 2). The resultant electrodes are capable of
detecting low levels of the antigen - ciprofloxacin. Control
electrodes containing non-specific IgG have also been fabricated and allow the
subtraction out of unspecific interactions.
EXPERIMENTAL
Sodium dihydrogen orthophosphate, disodium hydrogen orthophosphate,
sodium chloride, hydrochloric acid, were obtained from BDH (Poole, Dorset, UK).
Potassium chloride was obtained from Fisher Scientific UK Ltd, Loughborough, UK.
Aniline, polyclonal IgG from human serum, the biotinylation kit (part no. BK101),
biotin 3 -sulfo-N-hydroxysuccinimide, avidin, bovine serum albumin (BSA), potassium
ferrocyanide and potassium ferricyanide were obtained from Sigma-Aldrich,
Gillingham, Dorset, UK. All water used was obtained from a Purelab UHQ Deioniser
(Elga, High Wycombe, UK). Commercial screen-printed carbon electrodes (Figure 3)
containing carbon working and counter electrodes and an Ag/AgCl reference electrode
were obtained from Parlex Corp Ltd, Isle of Wight, UK. The surface area of the
working electrode was 0.2 178 cm2.
Phosphate Buffered Saline (PBS) at pH 7.4 stock solution was prepared
containing 0.14 mol l-1 NaH2PO4, 0.52 mol l-1 Na2HPO4 and 0.005 1 mol l-1 NaCl. Aniline
buffer (pH 1-2) was prepared containing 0.5 mol l-1 KCl, 0.3 mol l-1 HCl and 0.2 mol l-1
aniline.
Polyclonal antiserum (As 171) was raised against 1-(3mercaptopropyl)-6-fluoro-
7-(piperanicyl)- 1 ,4-dihydro-4-oxo-quinoline-3 -carboxylic acid coupled to HCH. The
preparation of the immunogen and of the antibodies will be described elsewhere
(Pinacho et al., 2007).
For antibody biotinylation the procedure outlined in the BK101 kit was followed
(see manufacturers instructions for details). Biotinylated antibodies were kept frozen in
aliquots of 200 Pl at a concentration of 1 mg ml-1 until required.
Cyclic voltammetry (Sycopel Potentiometer, Sycopel Scientific, Tyne & Wear,
UK) was utilised to deposit polyaniline films on the carbon electrodes. Screen-printed
carbon electrodes were placed in aniline buffer and cycled from -200 mV to +800 mV
vs. Ag/AgCl for approximately 20 cycles (occasionally this was varied slightly to
ensure the same amount of polyaniline was deposited on each electrode. Deposition was
terminated at +800 mV to ensure the polyaniline remained in its conducting form. After
deposition electrodes were rinsed in water.
30 μl of biotin-sulfo-NHS (10 mg ml-1 in water) was placed on the polymer
coated working electrode surface for 24 hours. The sensors were rinsed with copious
water and 30 μl of avidin (10 μg ml-1 in water) placed on the working electrode for 1
hour followed by rinsing in water. Then 30 μl biotinylated antibody (1 mg ml-1 in water)
was added followed by rinsing. Finally, non-specific interactions were blocked by BSA
(10-6 M in PBS); the sensors are ready to use at this point, however, if opted, can be
stored in PBS at 4oC for no longer than 24 hours.
AC impedance measurements were performed using an ACM Auto AC DSP
frequency response analyser. Antigen solutions for AC impedance were prepared by
diluting the required concentration of antigen in 30ml of PBS pH 7.4. A range of
concentrations were utilised, since genotoxicity is noted at levels above 5.2 ng ml-1; we
set our minimum level at 1 ng ml-1 with an upper limit of 10 Pg ml-1, which covers the
therapeutic/clinical range. However other work within our group suggests detection
limits of about 10 pg ml-1. The sensors were first interrogated without antigen addition.
Following this, each sensor was exposed to the required antigen
concentration for 30 minutes, rinsed well with deionised water and then subjected to
impedance interrogation. Potassium ferrocyanide (10 mM) and potassium ferricyanide
(10 mM) in PBS buffer were utilised as a redox couple for impedimetric measurements.
Three electrodes were used for each measurement. A frequency range from 10 kHz to 1
Hz was measured, with a peak amplitude of 5 mV and a DC offset of +400 mV against
Ag/AgCl.
RESULTS AND DISCUSSION
Deposition of polyaniline
The voltammograms for the deposition of polyaniline/DNA are depicted in Fig.
4 and imply a steady in situ formation of polymer at the electrode surface. As the
number of scans increases peaks appear between +350-400 mV vs Ag/AgCl
corresponding to the oxidation and reduction of surface bound polyaniline. The increase
in current from scan 10 to 20 is due to the increase in polyaniline thickness and
coverage of the electrode.
Impedance profiles of the electrodes
A series of Nyquist curves were obtained for the sensors after exposure to
various levels of ciprofloxacin in PBS (Figure 5a). As can be seen, there is a steady
decrease in the impedance of the electrodes with increasing antigen concentration. The
relative conductivities of the system, which are obtained by dividing the impedance for
each frequency with no antigen present - by the impedance (at the same frequency) for
each antigen concentration are shown in Figure 5b. As can be seen, we see much larger
increases in conductivity at the lower frequencies. Therefore
it was decided that changes in impedance at 1 Hz would be used as a measurement of
antigen binding.
The impedance spectra consists of two components, the real (Z') component
where the impedance in phase with the AC potential waveform is measured and the
imaginary (Z") where the impedance is 180o out of phase. It is important to differentiate
between the individual components of the total impedance of the cell so that the
capacitive and Faradaic components of the composite impedimetric response may be
identified and quantified. Previous work by our group showed that while both the
imaginary and real components increase, the increase in the real component dominated
the total increase in the impedance (Grant et al 2005). Although in this case changes in
both real and imaginary components are visible and again the real component is the
major component of total impedance, perhaps more importantly it was also found that
the real component offers far greater reproducibility in comparison to the imaginary
contribution.
Figure 6a shows the percentage decrease in Z' across a range of antigen
concentrations. As can be seen, there is a steady decrease in impedance as antigen
concentration increases up to a concentration of about 100 ng ml-1, above which
concentration there is a tend towards a plateau, possibly indicating saturation of the
specific binding sites. It is possible that any further changes in impedance beyond this
level could simply be due to non-specific interactions. Between a concentration range of
1-100 ng ml-1, there is a near linear correlation of the impedance change with the log10
of concentration (R2=0.96).
Non-specific interactions could potentially interfere with immunosensor performance.
This could be addressed by utilisation of a second sensor containing either no
antibodies - or alternatively a non-specific antibody. Therefore an identical set of
immunosensors were fabricated utilising a non-specific IgG antibody in place of the
specific ciprofloxacin antibody. Results for these electrodes were obtained in exactly
the same way and the calibration plot is shown (Figure 6b). As can be seen, there is a
much lower response for the non-specific antibody, showing that although there are
non-specific interactions, between the ranges of 1-100 ng ml-1, they comprise a minor
component of the detected response. Figure 6c shows the subtracted responses (6a-6b)
and again this demonstrates linearity between the response and the log10 of ciprofloxacin
concentration between 1-100 ng ml-1 (R2=0.96).
CONCLUSIONS
We have demonstrated the construction of an immunosensor for the antibiotic
ciprofloxacin using a combination of screen-printed electrodes coated with conducting
polyaniline and an immobilised polyclonal antibody. Interrogation of the electrodes by
AC impedance demonstrated the detection of the antigen. Linear correlation of the
impedance change with the log10 of concentration (R2=0.96) was observed between
concentrations of 1-100 ng ml-1.
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